Daewoong Pharmaceutical to Participates in CPHI Worldwide 2023, Showcasing Own Novel Drug in the Global Market

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Daewoong-CPHI

More Like This

PR Newswire associated0

Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA

PR Newswire associated0

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

Kexing Biopharm Attended CPHI Worldwide 2023

PR Newswire associated0

Yuyu Pharma to attend 'CPHI Worldwide 2023'

PR Newswire associated0

Daewoong Therapeutics Gets MFDS Nod for Phase 1 IND for the World's First Eyedrop Treatment for Diabetic Retinopathy and Macular Edema

PR Newswire associated0

Daewoong Pharmaceutical's Bersiporocin Receives 'Orphan Drug Designation' in Europe to Treat Idiopathic Pulmonary Fibrosis

PR Newswire associated0

Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative 'GLP-1 Obesity Treatment' with Advanced Microneedle Technology for Sustained Weekly Efficacy

2024 International Pharmaceutical Cooperation High-End Forum Kexing Biopharm's Series of Globalization Activities (China) Successfully Concluded